Skip to content

info@cv340b.org

Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowYouTube page opens in new window
Community Voices 340B
Community Voices 340B
  • What is 340B?
    • FAQ
  • Resources
  • Who We Are
    • Our Mission
    • Benefactor Program
  • News
  • Advocacy
    • #Defend340B Videos
    • Get Involved
    • Regional Advocacy Groups
    • CV340B Campaign
  • Contact Us
    • Send Us A Message
    • Tell Us More
Search:
  • What is 340B?
    • FAQ
  • Resources
  • Who We Are
    • Our Mission
    • Benefactor Program
  • News
  • Advocacy
    • #Defend340B Videos
    • Get Involved
    • Regional Advocacy Groups
    • CV340B Campaign
  • Contact Us
    • Send Us A Message
    • Tell Us More

Page

Recent Posts
  • Federal Judges Issue Decisions Regarding Safety-Net Provider Drug Dispensing Methods
  • Merck Restricts Purchases of 340B Drugs for 340B Hospitals Effective September 1st, 2021
  • Indiana District Court Holds Important Hearing on HRSA’s Enforcement and Eli Lilly’s 340B Price Restrictions
  • House of Representatives Approves Spanberger-McKinley Amendment Supporting HRSA Action Against Drug Manufacturer
  • On July 11, the U.S. House Appropriations Committee emphasizes the importance of the 340B program in HHS report
Archives
  • November 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2019
  • August 2019
  • June 2019
  • May 2019
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • August 2017
Categories
  • 340B
  • Clinic
  • Drug Prices
  • Uncategorized
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Find us on:

Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new window
Quick Links
  • Benefactor Program
  • Newsletter
  • Our Mission
More Information
  • Contact Us
  • FAQ’s
Go to Top